Heart disease and the risk of allopurinol-associated severe cutaneous adverse reactions: a general population–based cohort study

BACKGROUND: Allopurinol is commonly prescribed for gout, and its clinical use may expand with ongoing trials assessing its potential cardiorenal benefits. Because heart disease has been suggested to be a risk factor for allopurinol-associated severe cutaneous adverse reactions, we sought to confirm...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:CMAJ
Egile Nagusiak: Yokose, Chio, Lu, Na, Xie, Hui, Li, Lingyi, Zheng, Yufei, McCormick, Natalie, Rai, Sharan K., Aviña-Zubieta, J. Antonio, Choi, Hyon K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Joule Inc. 2019
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6773546/
https://ncbi.nlm.nih.gov/pubmed/31570545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/cmaj.190339
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak